Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 1/20 | 0.57 |
| ▸ | CRBN | Q96SW2 | 15/20 | 0.52 |
| ▸ | MAP1LC3B | Q9GZQ8 | 4/20 | 0.52 |
| ▸ | IKZF3 | Q9UKT9 | 3/20 | 0.52 |
| ▸ | DDB1 | Q16531 | 3/20 | 0.52 |
| ▸ | BRD4 | O60885 | 2/20 | 0.52 |
| ▸ | IKZF1 | Q13422 | 2/20 | 0.52 |
| ▸ | TNF | P01375 | 1/20 | 0.52 |
| ▸ | IL1B | P01584 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27271059 | 0.89 | CRBN (0.60) | STAT3CRBNMAP1LC3BIKZF3DDB1 | |
| SCHEMBL19451349 | 0.89 | STAT3 (0.59) | STAT3CRBNMAP1LC3BIKZF3DDB1 | |
| SCHEMBL19451346 | 0.86 | STAT3 (0.59) | STAT3CRBNMAP1LC3BIKZF3DDB1 | |
| SCHEMBL30189339 | 0.86 | STAT3 (0.65) | STAT3CRBNMAP1LC3BIKZF3DDB1 | |
| SCHEMBL22307127 | 0.86 | STAT3 (0.65) | STAT3CRBNMAP1LC3BIKZF3DDB1 | |
| SCHEMBL30189386 | 0.86 | STAT3 (0.65) | STAT3CRBNMAP1LC3BIKZF3DDB1 | |
| SCHEMBL21303964 | 0.86 | STAT3 (0.65) | STAT3CRBNMAP1LC3BIKZF3DDB1 | |
| SCHEMBL21303972 | 0.86 | STAT3 (0.67) | STAT3CRBNMAP1LC3BIKZF3DDB1 | |
| SCHEMBL17536588 | 0.85 | STAT3 (0.66) | STAT3CRBNMAP1LC3BIKZF3DDB1 | |
| SCHEMBL19451362 | 0.85 | STAT3 (0.64) | STAT3CRBNMAP1LC3BIKZF3DDB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220185808-A1 | ACYLAMINOPYRROLO-PYRIDONE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | SHANGHAI RINGENE BIOPHARMA CO., LTD. (CN) | 2022-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220185808-A1 | ACYLAMINOPYRROLO-PYRIDONE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | CYP4F11, CYP4A11, AASDHPPT | STAT3 3339/4885CRBN 4641/4885MAP1LC3B 1931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.